Newsletter

Stay up to date on all things colon cancer. Sign up and we’ll send you the latest news, resources, scientific breakthroughs, events, tips, and much more.

Reducing Rural Colon Cancer Disparities

November 21, 2019

Overview

This study is exploring the difference in outcomes for cancer patients in rural vs. urban areas. Southern Illinois will be used as the prime example of persistent poverty that can affect the outcome of one’s diagnosis. The aim is to develop a model which includes specially produced brochures and literary material and colonoscopy scheduling assistance.

 

Study Information

This clinical trial is estimated to have 1816 participants, with the primary purpose of prevention. The study began on September 8th 2017 and the predicted completion date is February 28th 2021.

 

Inclusion Criteria

 

  • Ages 50-75
  • Positive fecal occult blood test referral (FOBT) during the study period

 

Exclusion Criteria

  • No medical contra-indication for colonoscopy

 

Location

This clinical trial is taking place at two locations. For the Illinois location, it is taking place at Southern Illinois Healthcare, Carbondale, Illinois, United States, 62901. For further information, please contact Marci Moore-Connelley, M.D. on 618-536-6621 or at seniormanagement@sih.net. For the Missouri location, it is taking place at the Washington University School of Medicine, Saint Louis, Missouri, United States, 63110. For further information, please contact Aimee James, Ph.D., MPH on 314-454-8300 or at aimeejames@wustl.edu.

 

Sponsors/Collaborators

This study is sponsored by the Washington School of Medicine, National Institutes of Health (NIH) and National Cancer Institute (NCI). The Principal Investigator is Aimee James, Ph.D., MPH.

Clinical Trials

View All Clinical Trials

DC Vaccine in Colorectal Cancer

This study is assessing the safety, tolerability and immune response rate the of mDC3 vaccine in patients with colorectal cancer.

Diet Modulation of Bacterial Sulfur and Bile Acid Metabolism and Colon Cancer Risk

This diet-intervention trial focuses on African American subjects who are at higher risk for developing colorectal cancer (CRC). Two diets, one…

Green Tea and Milk Thistle to Colorectal Cancer Patients

Colorectal cancer is the third most common form of cancer found in the United States, and surgical resection (removal) provides the best chance for…

Participatory Research to Advance Colon Cancer Prevention

The goal of this study is to test strategies to raise rates of colorectal cancer screening among the Latino population. This study will be split…

Young-Onset Microsatellite-Stable Colorectal Cancer

The goal of this laboratory research study is to learn more about genetic factors that may influence the risk for developing colorectal cancer at a…

PalloV-CC in Colon Cancer

This study is looking at the effects of the PalloV CC vaccination on patients with colon cancer. The primary goals are to understand the safety of…

Exercise And Colon Cancer Treatment

This study is looking at how exercise may prevent the recurrence of colon cancer in patients who have completed their treatment. The primary…

Niclosamide in Patients With Resectable Colon Cancer

This study is examining the safety of the drug Niclosamide in patients with colon cancer that are undergoing primary resection (cutting out) of…

Make a comment and share this article on your profile.

Write a comment for your publication

Successfully Shared!

View on my Profile

Send this to a friend